Literature DB >> 31228200

Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization.

Krishna K Patel1,2, John A Spertus1,2, Paul S Chan1,2, Brett W Sperry1,2, Firas Al Badarin1,2, Kevin F Kennedy2, Randall C Thompson1,2, James A Case3, A Iain McGhie1,2, Timothy M Bateman1,2.   

Abstract

AIMS: Positron emission tomography (PET) myocardial perfusion imaging (MPI) can non-invasively measure myocardial blood flow reserve (MBFR). We aimed to examine whether MBFR identifies patients with a survival benefit after revascularization, helping to guide post-test management. METHODS AND
RESULTS: We examined all-cause mortality in 12 594 consecutive patients undergoing Rb82 rest/stress PET MPI from January 2010 to December 2016, after excluding those with cardiomyopathy, prior coronary artery bypass surgery (CABG), and missing MBFR. Myocardial blood flow reserve was calculated as the ratio of stress to rest absolute myocardial blood flow. A Cox model adjusted for patient and test characteristics, early revascularization (percutaneous coronary intervention or CABG ≤90 days of MPI), and the interaction between MBFR and early revascularization was developed to identify predictors of all-cause mortality. After a median follow-up of 3.2 years, 897 patients (7.1%) underwent early revascularization and 1699 patients (13.5%) died. Ischaemia was present in 4051 (32.3%) patients, with 1413 (11.2%) having ≥10% ischaemia. Mean MBFR was 2.0 ± 1.3, with MBFR <1.8 in 4836 (38.5%). After multivariable adjustment, every 0.1 unit decrease in MBFR was associated with 9% greater hazard of all-cause death (hazard ratio 1.09, 95% confidence interval 1.08-1.10; P < 0.001). There was a significant interaction between MBFR and early revascularization (P < 0.001); such that patients with MBFR ≤1.8 had a survival benefit with early revascularization, regardless of type of revascularization or level of ischaemia.
CONCLUSION: Myocardial blood flow reserve on PET MPI is associated with all-cause mortality and can identify patients who receive a survival benefit with early revascularization compared to medical therapy. This may be used to guide revascularization, and prospective validation is needed. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Myocardial blood flow reserve; Myocardial perfusion imaging; Positron emission tomography; Survival

Mesh:

Year:  2020        PMID: 31228200      PMCID: PMC7828468          DOI: 10.1093/eurheartj/ehz389

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  33 in total

1.  Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology?

Authors:  Nils P Johnson; Richard L Kirkeeide; K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

Review 2.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.

Authors:  K Lance Gould; Nils P Johnson; Timothy M Bateman; Rob S Beanlands; Frank M Bengel; Robert Bober; Paolo G Camici; Manuel D Cerqueira; Benjamin J W Chow; Marcelo F Di Carli; Sharmila Dorbala; Henry Gewirtz; Robert J Gropler; Philipp A Kaufmann; Paul Knaapen; Juhani Knuuti; Michael E Merhige; K Peter Rentrop; Terrence D Ruddy; Heinrich R Schelbert; Thomas H Schindler; Markus Schwaiger; Stefano Sdringola; John Vitarello; Kim A Williams; Donald Gordon; Vasken Dilsizian; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

Review 3.  Does coronary flow trump coronary anatomy?

Authors:  K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2009-08

4.  Evaluating the clinical impact of cardiovascular imaging: is a risk-based stratification paradigm relevant?

Authors:  Paul Schoenhagen; Rory Hachamovitch
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

5.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

Review 6.  Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.

Authors:  Kathleen Stergiopoulos; William E Boden; Pamela Hartigan; Sven Möbius-Winkler; Rainer Hambrecht; Whady Hueb; Regina M Hardison; J Dawn Abbott; David L Brown
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

7.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.

Authors:  Bernhard A Herzog; Lars Husmann; Ines Valenta; Oliver Gaemperli; Patrick T Siegrist; Fabian M Tay; Nina Burkhard; Christophe A Wyss; Philipp A Kaufmann
Journal:  J Am Coll Cardiol       Date:  2009-07-07       Impact factor: 24.094

8.  Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment.

Authors:  Tim P van de Hoef; Froukje Nolte; Mauro EchavarrÍa-Pinto; Martijn A van Lavieren; Peter Damman; Steven A J Chamuleau; Michiel Voskuil; Hein J Verberne; José P S Henriques; Berthe L F van Eck-Smit; Karel T Koch; Robbert J de Winter; Jos A E Spaan; Maria Siebes; Jan G P Tijssen; Martijn Meuwissen; Jan J Piek
Journal:  Heart       Date:  2014-04-11       Impact factor: 5.994

9.  Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study.

Authors:  Sergey V Nesterov; Emmanuel Deshayes; John O Prior; Juhani M Knuuti; Roberto Sciagrà; Leonardo Settimo; Jerome M Declerck; Xiao-Bo Pan; Keiichiro Yoshinaga; Chietsugu Katoh; Piotr J Slomka; Guido Germano; Chunlei Han; Ville Aalto; Adam M Alessio; Edward P Ficaro; Benjamin C Lee; Stephan G Nekolla; Kilem L Gwet; Robert A deKemp; Ran Klein; John Dickson; James A Case; Timothy Bateman
Journal:  JACC Cardiovasc Imaging       Date:  2014-10-08

10.  Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease.

Authors:  K Lance Gould; Nils P Johnson; Amanda E Roby; Tung Nguyen; Richard Kirkeeide; Mary Haynie; Dejian Lai; Hongjian Zhu; Monica B Patel; Richard Smalling; Sal Arain; Prakash Balan; Tom Nguyen; Anthony Estrera; Stefano Sdringola; Mohammad Madjid; Angelo Nascimbene; Pranav Loyalka; Biswajit Kar; Igor Gregoric; Hazem Safi; David McPherson
Journal:  J Nucl Med       Date:  2018-08-16       Impact factor: 10.057

View more
  21 in total

Review 1.  Utility of nuclear cardiovascular imaging in the cardiac intensive care unit.

Authors:  Aldo L Schenone; Erika Hutt; Paul Cremer; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2021-06-09       Impact factor: 5.952

2.  Relationship Between Myocardial Perfusion Imaging Abnormalities on Positron Emission Tomography and Anginal Symptoms, Functional Status, and Quality of Life.

Authors:  Krishna K Patel; Femina S Patel; Timothy M Bateman; Kevin F Kennedy; Poghni A Peri-Okonny; A Iain McGhie; Brett W Sperry; Leslee Shaw; Marcelo Di Carli; Randall C Thompson; Ibrahim M Saeed; Philip G Jones; John A Spertus
Journal:  Circ Cardiovasc Imaging       Date:  2022-02-15       Impact factor: 7.792

3.  Prognostic Relationship Between Coronary Artery Calcium Score, Perfusion Defects, and Myocardial Blood Flow Reserve in Patients With Suspected Coronary Artery Disease.

Authors:  Krishna K Patel; Poghni A Peri-Okonny; Raed Qarajeh; Femina S Patel; Brett W Sperry; A Iain McGhie; Randall C Thompson; Kevin F Kennedy; Paul S Chan; John A Spertus; Timothy M Bateman
Journal:  Circ Cardiovasc Imaging       Date:  2022-04-13       Impact factor: 7.792

4.  ASNC's thoughts on the AHA/ACC chest pain guidelines.

Authors:  Randall C Thompson; Mouaz H Al-Mallah; Rob S B Beanlands; Dennis A Calnon; Sharmila Dorbala; Lawrence M Phillips; Donna M Polk; Prem Soman
Journal:  J Nucl Cardiol       Date:  2021-11-15       Impact factor: 5.952

Review 5.  Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research.

Authors:  Prakriti Gaba; Bernard J Gersh; James Muller; Jagat Narula; Gregg W Stone
Journal:  Nat Rev Cardiol       Date:  2022-09-23       Impact factor: 49.421

6.  Relative Prognostic Significance of Positron Emission Tomography Myocardial Perfusion Imaging Markers in Cardiomyopathy.

Authors:  Merrill Thomas; Brett W Sperry; Poghni Peri-Okonny; Ali O Malik; A Iain McGhie; Ibrahim M Saeed; Paul S Chan; John A Spertus; Randall C Thompson; Timothy M Bateman; Krishna K Patel
Journal:  Circ Cardiovasc Imaging       Date:  2021-10-19       Impact factor: 8.589

7.  13 N-ammonia PET-derived right ventricular longitudinal strain and myocardial flow reserve in right coronary artery disease.

Authors:  Masateru Kawakubo; Michinobu Nagao; Atsushi Yamamoto; Risako Nakao; Yuka Matsuo; Koichiro Kaneko; Eri Watanabe; Akiko Sakai; Masayuki Sasaki; Shuji Sakai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-13       Impact factor: 10.057

8.  ASNC stands for #PatientFirst imaging.

Authors: 
Journal:  J Nucl Cardiol       Date:  2021-04       Impact factor: 5.952

9.  Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging.

Authors:  Timothy M Bateman; Gary V Heller; Rob Beanlands; Dennis A Calnon; James Case; Rob deKemp; E Gordon DePuey; Marcelo Di Carli; Emel C Guler; Venkatesh L Murthy; Jeffrey Rosenblatt; Ronald Sher; Piotr Slomka; Terrence D Ruddy
Journal:  J Nucl Med       Date:  2021-03-31       Impact factor: 11.082

10.  Quantitative Myocardial Perfusion Predicts Outcomes in Patients With Prior Surgical Revascularization.

Authors:  Andreas Seraphim; Benjamin Dowsing; Krishnaraj S Rathod; Hunain Shiwani; Kush Patel; Kristopher D Knott; Sameer Zaman; Ieuan Johns; Yousuf Razvi; Rishi Patel; Hui Xue; Daniel A Jones; Marianna Fontana; Graham Cole; Rakesh Uppal; Rhodri Davies; James C Moon; Peter Kellman; Charlotte Manisty
Journal:  J Am Coll Cardiol       Date:  2022-03-29       Impact factor: 27.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.